EADV 2025 News: Delgocitinib Cream (Anzupgo, LEO Pharma) Performs Well in Adolescents With Moderate-to-Severe CHE
Delgocitinib cream (Anzupgo, LEO Pharma) bested cream vehicle and was generally well-tolerated in adolescents with moderate-to-severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or inappropriate, according to new results from the DELTA TEEN Phase 3 trial.